EMA Explores Optimizing Vaccine Development In Immunocompromised Patients

 
• By Vibha Sharma
  
Senior woman receives a vaccination
Premarket clinical trials for new vaccines do not usually include immunocompromised individuals • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography